FinscoFinsco

Elanco Animal Health (US.ELAN)

Capital Allocation Audit · Period: 2015 – 2026

$Open the interactive terminal to run `audit` and explore all dimensions.→

Key Metrics

US.ELAN · YoY: 2026 Q1 vs 2025 Q1

MetricValueYoY
FCF Conversion-292.3%↓
ROE0.9%↓
Cash Conversion22.8%↑
D/E Ratio0.61↑
Gross Margin57.3%→
US.ELAN (Elanco Animal Health) | YoY: 2026 Q1 vs 2025 Q1


Metric             Value  YoY
-----------------------------
FCF Conversion   -292.3%    ↓
ROE                 0.9%    ↓
Cash Conversion    22.8%    ↑
D/E Ratio           0.61    ↑
Gross Margin       57.3%    →
Key Metrics
US.ELAN (Elanco Animal Health) | YoY: 2026 Q1 vs 2025 Q1
Metric Value YoY
-----------------------------
FCF Conversion -292.3% ↓
ROE 0.9% ↓
Cash Conversion 22.8% ↑
D/E Ratio 0.61 ↑
Gross Margin 57.3% →

Audit Dimensions

Capital FlowReturnsEarning QualityDebt DisciplineMoat

Unlimited Companies

AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies